BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Oncology

Agilent Announces Expansion of Portfolio With Acquisition of Avida Biomed

Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine Agilent T...

January 06, 2023 | News

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program Duality to receive upfr...

January 05, 2023 | News

The Best of 2022: FDA Approvals and the Breakthroughs That Enabled Them

For a field like cancer research, in which progress can sometimes appear to happen slowly, it is especially important to remind ourselves of the crucial ad...

December 31, 2022 | News | By Calley Jones, PhD

Non-invasive in vitro diagnostic (IVD) test enables early detection of colorectal cancer

Stool sample collection kit, DNA Isolation Kit and Sample Pretreatment Kit for Methylation Detection, which are used in conjunction with this detection pro...

December 28, 2022 | News

Merck Announces Collaboration With Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates

Collaboration complements Merck’s internal expertise and in-house ADC approach Companies focused on discovering novel STING-agonist ADCs for up to...

December 23, 2022 | News

Prenetics Acquires ACT Genomics

Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genom...

December 16, 2022 | News

Janssen Submits Biologics License Application to U.S. FDA

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a Biologics License Application (BLA) to the U.S. Food and ...

December 12, 2022 | News

Exact Sciences to Advance Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data for it...

December 12, 2022 | News

JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential

Presently, most cancer diagnosis is done through thinly sliced physical biopsies. Though widespread, the amount of information this method collects remains...

December 06, 2022 | News

How Optoacoustic Imaging Plays a Role in Assessing the Success of Breast Cancer Surgery

This first-in-human study was carried out by a team of researchers and clinicians at A*STAR’s Institute of Bioengineering and Bioimaging (IBB)&...

December 05, 2022 | News

Propanc Biopharma Concludes PRP Could Become an Effective Chemosensitizer Agent Against Pancreatic Cancer

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer tre...

December 02, 2022 | News

BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine

The complete manufacturing of BVX-0918 from a cancer patient's ovarian tumor now validates the production protocols that had been in development over the p...

December 02, 2022 | News

GE Healthcare Highlights Transformative Precision Innovations and Collaborations that Help Drive the Future of Health

Drawing on more than 100 years of history as a trusted medical technology innovator1, GE Healthcare is closely connected with healthcare systems globally. ...

November 28, 2022 | News

Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver more Medicines to Patients Faster

Company aims to launch one new product or indication every 1.5 years on average, bolstered by external innovation Phase III assets xevinapant and evobru...

November 23, 2022 | News

Stay Connected